SHERILYN KLAMM: Open Payments
NPI 1619154994 · KENOSHA, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$758 in 32 payments from 6 companies in 2025. Trend: 2023 $297 · 2024 $562 · 2025 $758
Food & beverage: $653Education: $105
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 8 | $248 |
| Neurocrine BioSciences, Inc. | 10 | $184 |
| Janssen Pharmaceuticals, Inc | 6 | $150 |
| Lundbeck LLC | 5 | $113 |
| Axsome Therapeutics, Inc. | 2 | $41 |
| Alkermes, Inc. | 1 | $23 |
Products named: INGREZZA, INVEGA SUSTENNA, ABILIFY ASIMTUFII, UZEDY, AUSTEDO XR, Auvelity, VIVITROL.
Industry payments across WI — which companies pay providers there.
